Get startedLog in
    Picture of Kalvista Pharmaceuticals logo

    KALV — Kalvista Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapMomentum Trap
    All News

    Brief: KalVista Pharmaceuticals Announces FDA Approval of EKTERLY

    Picture of Kalvista Pharmaceuticals logoKalvista Pharmaceuticals
    07/07/2025 11:49
    July 7 (Reuters) - Kalvista Pharmaceuticals Inc KALV.O:

KALVISTA PHARMACEUTICALS ANNOUNCES FDA APPROVAL OF EKTERLY® (SEBETRALSTAT), FIRST AND ONLY ORAL ON-DEMAND TREATMENT FOR HEREDITARY ANGIOEDEMA

KALVISTA PHARMACEUTICALS INC - LAUNCHES EKTERLY IN U.S., PRESCRIPTIONS AVAILABLE

Source text: ID:nBwbRg573a

Further company coverage: KALV.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Kalvista Pharmaceuticals

    See all news